Back |
home / stock / mito / mito message board
Subject | By | Source | When |
---|---|---|---|
i dont think all the money is made | saigai | investorshub | 05/06/2021 11:47:58 AM |
Beautiful charts! | seachops | investorshub | 01/23/2021 12:27:09 AM |
Company is getting ready to roll something out | Krspecialized | investorshub | 12/07/2020 9:18:24 PM |
What are you seeing? | J5150 | investorshub | 12/07/2020 8:08:29 PM |
Good things happening! | Krspecialized | investorshub | 12/07/2020 7:34:26 PM |
B/A 1.54X1.55 ARCA on both sides | TheFinalCD | investorshub | 11/04/2020 10:17:09 PM |
$MITO NEWS https://finance.yahoo.com/news/stealth-biotherapeutics-announces-development-financing-22 | TheFinalCD | investorshub | 11/04/2020 10:11:27 PM |
News coming!!! | Krspecialized | investorshub | 08/24/2020 8:41:27 AM |
Have been watching this one. | boston127 | investorshub | 05/13/2020 1:07:58 AM |
News, Short Squeeze, Breakout and More Instantly...
Stealth BioTherapeutics Corp. Company Name:
MITO Stock Symbol:
NYSE Market:
Stealth BioTherapeutics Corp. Website:
Stealth BioTherapeutics Corp Announces Completion of Merger PR Newswire BOSTON , Nov. 16, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the ...
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire SBT-272 Phase 1 safety and tolerability data support further clinical development SBT-272 was neuroprotective...
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders PR Newswire BOSTON , Oct. 7, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage biotechnology company focused o...